LifeStance Health Group (LFST) Set to Announce Earnings on Thursday

LifeStance Health Group (NASDAQ:LFST) is scheduled to be posting its quarterly earnings results before the market opens on Thursday, May 9th. Analysts expect LifeStance Health Group to post earnings of ($0.09) per share for the quarter. LifeStance Health Group has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Parties interested in listening to the company’s conference call can do so using this link.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings data on Wednesday, February 28th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.03). The firm had revenue of $280.60 million for the quarter, compared to the consensus estimate of $263.14 million. LifeStance Health Group had a negative return on equity of 12.66% and a negative net margin of 17.64%. On average, analysts expect LifeStance Health Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

LifeStance Health Group Stock Up 4.4 %

NASDAQ:LFST opened at $6.45 on Thursday. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.11 and a current ratio of 1.11. The company has a market cap of $2.47 billion, a PE ratio of -12.65 and a beta of 1.34. LifeStance Health Group has a 52-week low of $4.74 and a 52-week high of $9.59. The stock has a 50-day simple moving average of $6.42 and a 200 day simple moving average of $6.53.

Insider Buying and Selling

In other LifeStance Health Group news, insider Paula Cipollone sold 13,996 shares of LifeStance Health Group stock in a transaction on Monday, March 11th. The stock was sold at an average price of $6.93, for a total value of $96,992.28. Following the completion of the transaction, the insider now directly owns 293,562 shares of the company’s stock, valued at approximately $2,034,384.66. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider Paula Cipollone sold 13,996 shares of LifeStance Health Group stock in a transaction on Monday, March 11th. The stock was sold at an average price of $6.93, for a total value of $96,992.28. Following the transaction, the insider now owns 293,562 shares in the company, valued at approximately $2,034,384.66. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO David Bourdon sold 58,826 shares of LifeStance Health Group stock in a transaction on Monday, March 11th. The shares were sold at an average price of $6.93, for a total value of $407,664.18. Following the completion of the transaction, the chief financial officer now owns 433,856 shares in the company, valued at approximately $3,006,622.08. The disclosure for this sale can be found here. In the last ninety days, insiders sold 245,463 shares of company stock valued at $1,786,868. Insiders own 8.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Jefferies Financial Group raised their price target on LifeStance Health Group from $8.00 to $9.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. The Goldman Sachs Group raised their price objective on LifeStance Health Group from $8.00 to $9.00 and gave the company a “neutral” rating in a research report on Monday, March 4th. Morgan Stanley reaffirmed an “overweight” rating and issued a $10.00 price objective on shares of LifeStance Health Group in a research report on Monday, April 22nd. Finally, Barclays raised their price objective on LifeStance Health Group from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Thursday, February 29th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $8.83.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.